#Immunity

Megan O'Driscoll

meganodris

Our analysis on age-specific mortality and immunity patterns of SARS-CoV-2 has now been published @nature. We look at COVID-19 death data in 45 countries and 22 serostudies to investigate the

Donald Welsh

DonaldWelsh16

There is a predictable look to each new C19 scare tactic. The same academics, under the guise of pseudoscience, beat the panic drum, claiming the next phase is terrifying and

Kai Kupferschmidt

kakape

And now for the bad news. *sigh*It looks like #B117, the more transmissible variant first detected in England, has now picked up the E484K mutation as well. That is the

David Fisman

DFisman

Excellent to see new Canadian seroprevalence estimates from @CANBloodServ https://nationalpost.com/news/only-1-5-per-cent-of-canadians-report-covid-19-antibody-immunity-in-second-pandemic-wave-study I think there are some issues with how th

Nancy Baxter MD PhD

enenbee

This review of vaccination of COVID19 by Prof Raina Macintyre @KirbyInstitute is required viewingWell worth 34 minutes of your time, but watch at 1.75 speed if you are in a

Prof. Akiko Iwasaki

VirusesImmunity

I highly recommend these VRBPAC documents. There are so many amazing facts in here. One striking finding is this figure. People who received the Pfizer vaccine are protected from #COVID19

Neil O'Brien MP

NeilDotObrien

My piece below looks at Sweden. Recent days have seen Sweden’s Nordic neighbours Finland and Norway offer emergency medical assistance as Stockholm’s hospitals overflow & the King make an unprecedented

Deepti Gurdasani

dgurdasani1

John Bell - Regius Prof at Oxford - asked today at the scientific committee whether the difference in no. of deaths across countries can be attributed to some extent to

Isaac Bogoch

BogochIsaac

1/ @nature asked over 100 scientists if they felt that #COVID19 was going to become endemic & circulate on earth for years to come. ~90% felt this was a likely

Kai Kupferschmidt

kakape

Getting a lot of questions about vaccines and variants and why @moderna_tx is developing a booster based on variant discovered in South Africa if vaccines are thought to protect against

Lindsay Wiley

ProfLWiley

Confusion over various endpoints for the covid pandemic is flaring up again. Eradication, elimination, containment, suppression, transition to seasonal/endemic covid, etc. are terms that even scientists use in inconsistent ways.

Joel Smalley

RealJoelSmalley

Did COVID come into England from the South East? Did the South East attain immunity before interventions could have any effect? Did the rest of the country have some limited

Vincent Rajkumar

VincentRK

Breaking: Over 50% of Delhi is seropositive for COVID. @ndtv @divyanshu @rishika625 @GargiRawat @nramind @bimalarya This supports my earlier thread on protection through cross reactive immunity. Otherwise the loss of

Eric Feigl-Ding

DrEricDing

Worrisome discovery—Among placebo group for Novavax’s vaccine in South Africa: people with prior #COVID19 infections appeared just as likely to get sick as people without prior infections—means past infection wasn’t

Kim Weeden

WeedenKim

Hard to believe but in academic time, fall 2021 is just around the corner. Delays in vaccination program make this extremely challenging for universities, in many ways more challenging than

Infectious Diseases

InfectiousDz

So what do we know about the Pfizer vaccine.1. Great news: vaccine, so far, 90% effective in reducing symptomatic COVID, as opposed to saline injection2. Study enrolled 43,538 volunteers and

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.